Previous Article | Next Article 
Molecular and Cellular Biology, August 2001, p. 5678-5687, Vol. 21, No. 16
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.16.5678-5687.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
The Elongation Domain of ELL Is Dispensable but
Its ELL-Associated Factor 1 Interaction Domain Is Essential for
MLL-ELL-Induced Leukemogenesis
Roger T.
Luo,1
Catherine
Lavau,2,*
Changchun
Du,2
Federico
Simone,1
Paul E.
Polak,1
Shin
Kawamata,2 and
Michael
J.
Thirman1,*
Section of Hematology/Oncology, University of
Chicago, Chicago, Illinois 60637,1 and
Systemix, Palo Alto, California 943042
Received 29 December 2000/Returned for modification 28 February
2001/Accepted 8 May 2001
The MLL-ELL chimeric gene is the product of the
(11;19)(q23p13.1) translocation associated with de novo and
therapy-related acute myeloid leukemias (AML). ELL is an RNA polymerase
II elongation factor that interacts with the recently identified EAF1
(ELL associated factor 1) protein. EAF1 contains a limited region of
homology with the transcriptional activation domains of three other
genes fused to MLL in leukemias, AF4, LAF4, and AF5q31. Using an in vitro transformation assay of retrovirally transduced myeloid progenitors, we conducted a structure-function analysis of MLL-ELL. Whereas the elongation domain of ELL was dispensable, the EAF1 interaction domain of ELL was critical to the immortalizing properties of MLL-ELL in vitro. To confirm these results in vivo, we transplanted mice with bone marrow transduced with MLL fused to the minimal EAF1
interaction domain of ELL. These mice all developed AML, with a longer
latency than mice transplanted with the wild-type MLL-ELL fusion. Based
on these results, we generated a heterologous MLL-EAF1 fusion gene and
analyzed its transforming potential. Strikingly, we found that MLL-EAF1
immortalized myeloid progenitors in the same manner as that of MLL-ELL.
Furthermore, transplantation of bone marrow transduced with MLL-EAF1
induced AML with a shorter latency than mice transplanted with the
MLL-ELL fusion. Taken together, these results indicate that the
leukemic activity of MLL-ELL requires the EAF1 interaction domain of
ELL, suggesting that the recruitment by MLL of a transactivation domain
similar to that in EAF1 or the AF4/LAF4/AF5q31 family may be a critical common feature of multiple 11q23 translocations. In addition, these
studies support a critical role for MLL partner genes and their protein-protein interactions in 11q23 leukemogenesis.
*
Corresponding author. Mailing address for Michael J. Thirman: 5841 South Maryland Ave., MC2115, Chicago, IL 60637. Phone: (773) 702-4133. Fax: (773) 702-8702. E-mail:
mthirman{at}medicine.bsd.uchicago.edu. Present address for
Catherine Lavau: CNRS UPR9051, IUH, Paris 75010, France. E-mail:
catlav{at}chu-stlouis.fr.
Molecular and Cellular Biology, August 2001, p. 5678-5687, Vol. 21, No. 16
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.16.5678-5687.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Zhou, J., Feng, X., Ban, B., Liu, J., Wang, Z., Xiao, W.
(2009). Elongation Factor ELL (Eleven-Nineteen Lysine-rich Leukemia) Acts as a Transcription Factor for Direct Thrombospondin-1 Regulation. J. Biol. Chem.
284: 19142-19152
[Abstract]
[Full Text]
-
Slany, R. K.
(2009). The molecular biology of mixed lineage leukemia. haematol
94: 984-993
[Abstract]
[Full Text]
-
Liu, J.-X., Hu, B., Wang, Y., Gui, J.-F., Xiao, W.
(2009). Zebrafish eaf1 and eaf2/u19 Mediate Effective Convergence and Extension Movements through the Maintenance of wnt11 and wnt5 Expression. J. Biol. Chem.
284: 16679-16692
[Abstract]
[Full Text]
-
Ono, R., Ihara, M., Nakajima, H., Ozaki, K., Kataoka-Fujiwara, Y., Taki, T., Nagata, K.-i., Inagaki, M., Yoshida, N., Kitamura, T., Hayashi, Y., Kinoshita, M., Nosaka, T.
(2005). Disruption of Sept6, a Fusion Partner Gene of MLL, Does Not Affect Ontogeny, Leukemogenesis Induced by MLL-SEPT6, or Phenotype Induced by the Loss of Sept4. Mol. Cell. Biol.
25: 10965-10978
[Abstract]
[Full Text]
-
Gerber, M. A., Shilatifard, A., Eissenberg, J. C.
(2005). Mutational Analysis of an RNA Polymerase II Elongation Factor in Drosophila melanogaster. Mol. Cell. Biol.
25: 7803-7811
[Abstract]
[Full Text]
-
Kong, S. E., Banks, C. A. S., Shilatifard, A., Conaway, J. W., Conaway, R. C.
(2005). ELL-associated factors 1 and 2 are positive regulators of RNA polymerase II elongation factor ELL. Proc. Natl. Acad. Sci. USA
102: 10094-10098
[Abstract]
[Full Text]
-
Pascual-Le Tallec, L., Simone, F., Viengchareun, S., Meduri, G., Thirman, M. J., Lombes, M.
(2005). The Elongation Factor ELL (Eleven-Nineteen Lysine-Rich Leukemia) Is a Selective Coregulator for Steroid Receptor Functions. Mol. Endocrinol.
19: 1158-1169
[Abstract]
[Full Text]
-
Ayton, P. M., Chen, E. H., Cleary, M. L.
(2004). Binding to Nonmethylated CpG DNA Is Essential for Target Recognition, Transactivation, and Myeloid Transformation by an MLL Oncoprotein. Mol. Cell. Biol.
24: 10470-10478
[Abstract]
[Full Text]
-
Sims, R. J. III, Belotserkovskaya, R., Reinberg, D.
(2004). Elongation by RNA polymerase II: the short and long of it. Genes Dev.
18: 2437-2468
[Abstract]
[Full Text]
-
Eguchi, M., Eguchi-Ishimae, M., Greaves, M.
(2004). The small oligomerization domain of gephyrin converts MLL to an oncogene. Blood
103: 3876-3882
[Abstract]
[Full Text]
-
Yam, J. W. P., Jin, D.-Y., So, C. W., Chan, L. C.
(2004). Identification and characterization of EBP, a novel EEN binding protein that inhibits Ras signaling and is recruited into the nucleus by the MLL-EEN fusion protein. Blood
103: 1445-1453
[Abstract]
[Full Text]
-
Zeisig, B. B., Milne, T., Garcia-Cuellar, M.-P., Schreiner, S., Martin, M.-E., Fuchs, U., Borkhardt, A., Chanda, S. K., Walker, J., Soden, R., Hess, J. L., Slany, R. K.
(2004). Hoxa9 and Meis1 Are Key Targets for MLL-ENL-Mediated Cellular Immortalization. Mol. Cell. Biol.
24: 617-628
[Abstract]
[Full Text]
-
Ferrando, A. A., Armstrong, S. A., Neuberg, D. S., Sallan, S. E., Silverman, L. B., Korsmeyer, S. J., Look, A. T.
(2003). Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. Blood
102: 262-268
[Abstract]
[Full Text]
-
Wiederschain, D., Kawai, H., Gu, J., Shilatifard, A., Yuan, Z.-M.
(2003). Molecular Basis of p53 Functional Inactivation by the Leukemic Protein MLL-ELL. Mol. Cell. Biol.
23: 4230-4246
[Abstract]
[Full Text]
-
Polak, P. E., Simone, F., Kaberlein, J. J., Luo, R. T., Thirman, M. J.
(2003). ELL and EAF1 are Cajal Body Components That Are Disrupted in MLL-ELL Leukemia. Mol. Biol. Cell
14: 1517-1528
[Abstract]
[Full Text]
-
Simone, F., Luo, R. T., Polak, P. E., Kaberlein, J. J., Thirman, M. J.
(2003). ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties. Blood
101: 2355-2362
[Abstract]
[Full Text]
-
So, C. W., Cleary, M. L.
(2003). Common mechanism for oncogenic activation of MLL by forkhead family proteins. Blood
101: 633-639
[Abstract]
[Full Text]
-
So, C. W., Cleary, M. L.
(2002). MLL-AFX Requires the Transcriptional Effector Domains of AFX To Transform Myeloid Progenitors and Transdominantly Interfere with Forkhead Protein Function. Mol. Cell. Biol.
22: 6542-6552
[Abstract]
[Full Text]
-
Dash, A. B., Williams, I. R., Kutok, J. L., Tomasson, M. H., Anastasiadou, E., Lindahl, K., Li, S., Van Etten, R. A., Borrow, J., Housman, D., Druker, B., Gilliland, D. G.
(2002). A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9. Proc. Natl. Acad. Sci. USA
99: 7622-7627
[Abstract]
[Full Text]